By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent reported after the close of the markets on Monday that revenues grew 16 percent during its fiscal second quarter, as its Electronics Measurement Group rebounded from recent woes to post an 18 percent bounce year over year.

Agilent reported total revenues of $1.27 billion for the three-month period ended April 30, compared to $1.09 billion for the second quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.